Demadex and Apresoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Demadex (torsemide) and Apresoline (hydralazine hydrochloride). Common drug interactions include hypocalcaemia among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Demadex and Apresoline. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Demadex?

Demadex has active ingredients of torsemide. It is often used in heart failure. eHealthMe is studying from 5,358 Demadex users. Check the latest studies of Demadex.

What is Apresoline?

Apresoline has active ingredients of hydralazine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,475 Apresoline users. Check the latest studies of Apresoline.



On Jul, 25, 2026

72 people who take Demadex and Apresoline together, and have interactions are studied.

Demadex and Apresoline drug interactions.

What are the common drug interactions of Demadex and Apresoline, by gender? *:

female:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Urinary tract infection
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Anxiety
  5. Injury
  6. Pain
  7. Pain in jaw
  8. Abdominal pain upper
  9. Disability
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

  1. Cardiac failure congestive
  2. Nausea (feeling of having an urge to vomit)
  3. Balance disorder
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Insomnia (sleeplessness)
  6. Pain
  7. Cerebral haemorrhage (bleeding within the brain)
  8. Anaemia (lack of blood)
  9. Anaphylactic reaction (serious allergic reaction)
  10. Anoxic encephalopathy (brain damage due to lack of oxygen)

What are the common drug interactions of Demadex and Apresoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood glucose increased
  2. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Pitting oedema (skin discoloration)

40-49:

  1. Cardiac failure congestive
  2. Cardiac failure acute
  3. Chest pain
  4. Chronic kidney disease
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Decreased appetite
  7. Dyspnoea (difficult or laboured respiration)
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. General physical health deterioration (weak health status)
  10. Hypoxia (low oxygen in tissues)

50-59:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Disability
  3. Dyspnoea (difficult or laboured respiration)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Haematuria (presence of blood in urine)
  6. International normalised ratio increased
  7. Pancreatitis chronic (chronic inflammation of pancreas)
  8. Rectal haemorrhage (bleeding from anus)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Viral upper respiratory tract infection

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Abdominal pain upper
  5. Anxiety
  6. Dizziness
  7. Injury
  8. Pain in jaw
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Diabetes: 12 people, 16.67%
  2. Constipation: 11 people, 15.28%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 15.28%
  4. Pain: 11 people, 15.28%
  5. Type 2 Diabetes: 10 people, 13.89%
  6. Anaemia (lack of blood): 8 people, 11.11%
  7. Chest Pain: 7 people, 9.72%
  8. Oedema Peripheral (superficial swelling): 7 people, 9.72%
  9. Joint Pain: 6 people, 8.33%
  10. Dizziness: 6 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Demadex and Apresoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Demadex and Apresoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Demadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Apresoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Demadex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apresoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on torsemide and hydralazine hydrochloride (the active ingredients of Demadex and Apresoline, respectively), and Demadex and Apresoline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: